Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 3 May 24 424B5 Prospectus supplement for primary offering
- 3 Jul 23 424B5 Prospectus supplement for primary offering
- 7 Jun 23 424B5 Prospectus supplement for primary offering
- 29 Mar 23 424B5 Prospectus supplement for primary offering
- 12 Oct 22 424B5 Prospectus supplement for primary offering
- 19 Jul 22 424B5 Prospectus supplement for primary offering
- 17 Dec 21 424B5 Prospectus supplement for primary offering
- 16 Dec 21 424B5 Prospectus supplement for primary offering
- 19 Nov 21 424B5 Prospectus supplement for primary offering
- 25 Oct 21 EFFECT Notice of effectiveness
-
19 Oct 21 S-3/A Shelf registration (amended)
- 27 Aug 21 S-3/A Shelf registration (amended)
- 7 Jun 21 S-3 Shelf registration
ABEO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 (Amendment No. 2) of our report dated March 24, 2021, relating to the consolidated financial statements, which appear in Abeona Therapeutics Inc.’s Annual Report on Form 10-K for the year ended December 31, 2020. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
/s/ WHITLEY PENN LLP
Plano, Texas
October 19, 2021